United Therapeutics (UTHR) Asset Utilization Ratio (2010 - 2026)
United Therapeutics' (UTHR) Asset Utilization Ratio came in at 0.45 for Q2 2026, up 15.1% from 0.39 a year earlier and up 4.2% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
For FY2025, United Therapeutics' Asset Utilization Ratio stood at 0.42, up 5.4% from FY2024.
- Annual Asset Utilization Ratio has increased for four consecutive years.
- In prior years, United Therapeutics' Asset Utilization Ratio was 0.40 in FY2024 (+12.4%), 0.35 in FY2023 (+2.0%), 0.35 in FY2022 (+0.2%) and 0.34 in FY2021 (-1.0%).
- The Q2 2026 figure stands as the highest quarterly Asset Utilization Ratio since Q4 2018.
- On a year-over-year basis, Asset Utilization Ratio has increased in each of the last four quarters, with growth averaging 10.7% over the last eight quarters.
- The strongest year-over-year quarter for Asset Utilization Ratio in the past five years was Q3 2024, with growth of 23.8%; the weakest was Q1 2023, with a decline of 4.8%.
- According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.43 (Q1 2026), 0.42 (Q4 2025) and 0.41 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 0.31 |
| 10 | United Therapeutics | 24.02 Bn | 13.52 Bn | 683.80 Mn | 0.45 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.45 |
| Mar 31, 2026 | 0.43 |
| Dec 31, 2025 | 0.42 |
| Sep 30, 2025 | 0.41 |
| Jun 30, 2025 | 0.39 |
| Mar 31, 2025 | 0.40 |
| Dec 31, 2024 | 0.40 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | 0.40 |
| Mar 31, 2024 | 0.37 |
| Dec 31, 2023 | 0.33 |
| Sep 30, 2023 | 0.32 |
| Jun 30, 2023 | 0.32 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.33 |
| Jun 30, 2022 | 0.33 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.33 |
| Sep 30, 2021 | 0.33 |
API Access
United Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();